Aquestive Therapeutics, Inc.
AQST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,137 | -$7,870 | -$54,410 | -$70,539 |
| Dep. & Amort. | $718 | $1,345 | $2,387 | $2,964 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,099 | $2,689 | $4,381 | $6,819 |
| Change in WC | -$9,957 | -$5,341 | $32,007 | -$1,730 |
| Other Non-Cash | $10,518 | $2,797 | $5,846 | $29,507 |
| Operating Cash Flow | -$35,759 | -$6,380 | -$9,789 | -$32,979 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$159 | -$995 | -$2,524 | -$913 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$159 | -$995 | -$2,524 | -$913 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$23 | -$20,385 | -$2,025 | $0 |
| Stock Issued | $83,757 | $8,912 | $13,586 | $29,780 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$142 | $15,447 | $1 | $329 |
| Financing Cash Flow | $83,592 | $3,974 | $11,562 | $30,109 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $47,674 | -$3,401 | -$751 | -$3,783 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,872 | $27,273 | $28,024 | $31,807 |
| End Cash | $71,546 | $23,872 | $27,273 | $28,024 |
| Free Cash Flow | -$35,918 | -$7,375 | -$12,313 | -$33,892 |